Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?

Matthew L. White, Yan Zhang, Patricia Kirby, Timothy C. Ryken

PubMed · 2005 · 119 citations · 12 references

Full text

Open access

Abstract

Tumor contrast enhancement was not statistically significantly different between the tumor groups. We believe that the presence or absence of tumor contrast enhancement is not a specific finding for simply discriminating low-grade from anaplastic oligodendrogliomas. Histologic confirmation is necessary even in tumors without contrast enhancement.

References

12